4-(4-((4'-Chloro(1,1'-biphenyl)-2-yl)methyl)-1-piperazinyl)-N-((4-(((1R)-3-(dimethylamino)-1-((phenylthio)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)benzamide

InChIKey	`HPLNQCPCUACXLM-PGUFJCEWSA-N`
Compound Name	4-(4-((4'-Chloro(1,1'-biphenyl)-2-yl)methyl)-1-piperazinyl)-N-((4-(((1R)-3-(dimethylamino)-1-((phenylthio)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)benzamide
Canonical SMILES	`CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	11
Pfam Stratification	Cross-Family
Avg pChEMBL	8.32
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

DrugBank ID	DB17023
Drug Name	ABT-737
CAS Number	852808-04-9
Groups	experimental
ATC Codes	nan
Description	An inhibitor of members of the Bcl‑2 family of apoptosis regulators.[A252977]

Categories: Amides Benzene Derivatives Nitro Compounds Phenols Proto-Oncogene Proteins c-bcl-2 Sulfones Sulfur Compounds

Cross-references: BindingDB: 21447 ChEBI: 47575 CHEMBL376408 ChemSpider: 9403232 PDB: N3C Wikipedia: ABT-737 ZINC: ZINC000094303099

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q9BXH1	BBC3	Homo sapiens	Human	PF15826	9.5	IC50	ChEMBL
Q92934	BAD	Homo sapiens	Human	PF10514	9.2	Ki	ChEMBL;BindingDB
O15151	MDM4	Homo sapiens	Human	PF13920 PF00641	9.1	Ki	ChEMBL
P04637	TP53	Homo sapiens	Human	PF00870 PF08563 PF07710 PF18521	9.1	Ki	ChEMBL
O43521	BCL2L11	Homo sapiens	Human	PF08945 PF06773	8.7	IC50	ChEMBL
P10415	BCL2	Homo sapiens	Human	PF00452 PF02180	8.2	IC50	ChEMBL;BindingDB
Q07817	BCL2L1	Homo sapiens	Human	PF00452 PF02180	8.0	Ki	ChEMBL;BindingDB
Q07812	BAX	Homo sapiens	Human	PF00452	7.6	IC50	ChEMBL
Q16611	BAK1	Homo sapiens	Human	PF00452	7.6	IC50	ChEMBL
P55957	BID	Homo sapiens	Human	PF06393	7.3	IC50	ChEMBL
Q92843	BCL2L2	Homo sapiens	Human	PF00452 PF02180	7.2	IC50	ChEMBL;BindingDB

Target	Gene	Target Name	Action	Type
P10415	BCL2	Apoptosis regulator Bcl-2	inhibitor	targets